DRKS00000342已完成3 期
Monocentric, randomised, double-blind, placebo-controlled pilot study in double-dummy design in overweight or obese patientsto compare two treatment regimes (Polyglucosamine L112 vs. Orlistat 60 mg).
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 21 Years 至 60 Years（—）
- 性别
- All
入选标准
- •Overweight with a BMI > 28
- •Women: waist circumference > 80 cm
- •Men: waist circumference > 94 cm
排除标准
- •Pregnancy or breast-feeding
- •Alcohol-, medication- or drugdependency
- •Unability to fulfil the criteria of the trial protocol
- •Cancer, malignoma
- •Known hypersensivity against crustaceans or one of the excipients
- •Existing chronic, intestinal diseases, like a required treatment because of an constipation
- •After intestinal surgery
- •Diabetes mellitus
- •Chronic malabsorption syndrome
- •Cholestasis
- •Concomitant treatment with cyclosporines, warfarin or other anticoagulants
- •Liver-malfunctions with transaminases two times above ULN and/or
- •kidney-malfunctions according a cratinine-clearance above 80ml/min/1.73m²
- •Taken steroidhormones, could be reduced in their effect
- •Co-medication: concomitant treatment with
- •- cyclosporines
- •- warfarin or other oral anticoagulants
- •- beta-blocker
- •- neuroleptica and
- •- antidepressants is an exclusion criteria.
研究者
相似试验
已完成
4 期
Multicentric, randomised, double-blind, placebo-controlled 12-months-study in overweight or obese patients to compare two treatment regimes (polyglucosamine L112 vs. placebo)E66.00E66.01DRKS00000358Certmedica International GmbH100
已完成
Unknown
Monocentre, randomized, double-blind, placebo-controlled, parallel-group in vivo study to evaluate the effects of the food supplement Hamaforton™ (Hamamelis virginiana L. Extract)Only healthy subjectsDRKS00032925IUF - Leibniz-Institut für umweltmed. Forschung GmbH60
进行中（未招募）
不适用
Double-blind, placebo controlled, randomised, monocenter cross-over studie to evaluate the effect of Desmopressin on the nocturnal polyuria in patients with idiopathic Parkinson Syndrome compared to placebo. - DEPOPAEffect of Desmopressin on the nocturnal polyuria in patients with idiopathic Parkinson SyndromeMedDRA version: 9.1Level: LLTClassification code 10064016Term: Nocturnal polyuriaMedDRA version: 9.1Level: LLTClassification code 10061536Term: Parkinson's diseaseEUCTR2008-003966-25-DEniversität Mainz, Klinik und Poliklinik für Neurologie20
进行中（未招募）
1 期
Study evaluating the efficacy of bezafibrate for people suffering of primary sclerosing cholangitisAdult patients with primary sclerosing cholangitisEUCTR2019-001015-23-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)104
已完成
不适用
Efficacy of Aripiprazole in Combination with Valproate or Lithium in the Treatment of Mania in Patients with Bipolar I Disorder Partially Nonresponsive to Valproate or Lithium Monotherapy-F31F31PER-006-05BRISTOL MYERS SQUIBB COMPANY,